For acne sufferers whose skin has become resistant to ointments and medications, or for those who simply want to eliminate the use of oral antibiotics or Accutane, blue light acne therapy in conjunction with the use of Levulan has become a popular treatment option. Blue light therapy offers acne treatment that is gentle and non-invasive when used alone or as a part of photodynamic therapy with Levulan.
Blue light therapy in conjunction with Levulan acne treatment involves three mechanisms of action against acne. Levulan treatment inactivates the bacteria that trigger acne, exfoliates the skin to unclog pores, and the most exciting mechanism is that Levulan treatment shuts down the sebaceous glands in the skin. This is exciting because sebaceous glands are the root cause in the formation of acne so it has a long lasting effect even on severe acne.
Levulan with blue light therapy is a very safe alternative to Accutane treatment. Accutane also targets the sebaceous gland, but has fairly significant side effects.
Acne is not exclusive to teenagers. Many adults suffer with outbreaks. Blue light therapy may be something for you to try. Contact Hopkins Dermatology to schedule an appointment.
Levulan® Photodynamic Therapy (Levulan PDT) is an advanced treatment for actinic keratoses (AKs), or rough-textured, dry, scaly patches on the skin that can lead to skin cancer. Levulan PDT, a 2-part treatment course, is unique because it uses a light activated drug therapy to destroy AKs.
Levulan® Kerastick® Topical Solution is applied to the AK. The solution is then absorbed by the AK cells where it is converted to a chemical that makes the cells extremely sensitive to light. When the AK cells are exposed to the BLU-U® blue light illuminator, a reaction occurs which destroys the AK cells.
The short, 2-part treatment course is convenient and fits your lifestyle:
• Low downtime*
• No prescription to fill
• No daily medication to remember
• Excellent cosmetic response1
• No scarring reported to date
*Patients treated with Levulan PDT should avoid exposure of the photosensitized lesions to sunlight or prolonged or intense light for at least 40 hours.
1Data on file; DUSA Pharmaceuticals, Inc.®